ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition

被引:55
|
作者
Roberts, Kathryn G. [1 ]
Janke, Laura J. [1 ]
Zhao, Yaqi [1 ]
Seth, Aman [2 ]
Ma, Jing [1 ]
Finkelstein, David [3 ]
Smith, Steve [4 ]
Ebata, Kevin [4 ]
Tuch, Brian B. [4 ]
Hunger, Stephen P. [5 ,6 ,7 ]
Mullighan, Charles G. [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Pathol, 262 Danny Thomas Pl, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA
[4] Loxo Oncol, San Francisco, CA USA
[5] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA
[6] Univ Penn, Childrens Hosp Philadelphia, Ctr Childhood Res, Philadelphia, PA 19104 USA
[7] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
GENE FUSION; KINASE; ETV6; ONCOGENE; EVENT; LINE;
D O I
10.1182/blood-2018-05-849554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:861 / 865
页数:5
相关论文
共 2 条
  • [1] Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia
    Kralik, Johanna M.
    Kranewitter, Wolfgang
    Boesmueller, Hans
    Marschon, Renate
    Tschurtschenthaler, Gertraud
    Rumpold, Holger
    Wiesinger, Kurt
    Erdel, Martin
    Petzer, Andreas L.
    Webersinke, Gerald
    DIAGNOSTIC PATHOLOGY, 2011, 6
  • [2] Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3-Positive Acute Myeloid Leukemia
    Smith, Kristen M.
    Fagan, Patrick C.
    Pomari, Elena
    Germano, Giuseppe
    Frasson, Chiara
    Walsh, Colin
    Silverman, Ian
    Bonvini, Paolo
    Li, Gang
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (02) : 455 - 463